Several participants who began the intervention from a chair were completing the exercise standing up by the end.
Notably, results were achieved without maintenance therapy.
There was a significant association between the average GCIP thickness and MSFC scores.
The new drug shows promise in the treatment of PPMS, for which there are currently no approved treatments.
The material of the device may play a significant role in the relationship.
Patients taking oral DMDs were more likely to experience relapse in the first year.
A comprehensive approach to managing depression may have far-reaching effects.
At follow-up, 22 patients were cognitively impaired compared to 34 at baseline.
Early screening is paramount to identifying patients at risk for suicide.
Neurology Advisor reviews the upcoming agenda for the CMSC annual meeting.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics